Hematology NewsHydroxychloroquine-triggered QTc-interval prolongations mount in COVID-19 patientsMay 4, 2020COVID-19 UpdatesMixed Topics
Hematology NewsCOVID-19: To have and to hold ... in quarantineMay 4, 2020COVID-19 UpdatesPreventive Care
Hematology NewsCMS hikes telephone visit payments during pandemicMay 1, 2020COVID-19 UpdatesBusiness of Medicine
Hematology NewsPrimary care physicians reshuffle their work, lives in a pandemicMay 1, 2020COVID-19 UpdatesBusiness of Medicine
Hematology NewsOut-of-hospital cardiac arrests soar during COVID-19 in ItalyMay 1, 2020COVID-19 UpdatesMixed Topics
Oncology PracticeExcess cancer deaths predicted as care is disrupted by COVID-19May 1, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerCOVID-19 UpdatesGastroenterologyGenitourinary CancerGynecologic Cancer
Hematology NewsNew study of diabetes drug for COVID-19 raises eyebrowsMay 1, 2020COVID-19 UpdatesMixed Topics
Hematology NewsCase series suggests biologics, JAK inhibitors safe during pandemicMay 1, 2020COVID-19 UpdatesGastroenterologyGastrointestinal Cancer
Oncology PracticeAntitumor treatment may increase risk of severe events in COVID-19 patientsMay 1, 2020Patient & Survivor CareBreast CancerCOVID-19 UpdatesGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Oncology PracticeYale’s COVID-19 inpatient protocol: Hydroxychloroquine plus/minus tocilizumabApril 30, 2020COVID-19 Updates
Hematology NewsPOPCoRN network mobilizes pediatric capacity during pandemicApril 30, 2020PediatricsCOVID-19 Updates
